Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Quarterly results
|
|
PTC THERAPEUTICS, INC. (PTCT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/17/2023 |
4
| Gravier Pierre (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 26,000 shares
@ $0
Granted 65,000 options to buy
@ $39.82, valued at
$2.6M
|
|
| 06/09/2023 |
4
| SCHMERTZLER MICHAEL (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 1,000 shares
@ $44.86, valued at
$44.9k
|
|
| 06/07/2023 |
4
| Bell William F. Jr. (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 4,000 shares
@ $0
Granted 2,333 shares
@ $0
Granted 10,000 options to buy
@ $45.015, valued at
$450.2k
Granted 5,834 options to buy
@ $45.015, valued at
$262.6k
|
|
| 05/24/2023 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 173 shares
@ $59.5242, valued at
$10.3k
Sold 2,995 shares
@ $59.5335, valued at
$178.3k
Sold 3,948 shares
@ $59.5313, valued at
$235k
Sold 157 shares
@ $59.5171, valued at
$9.3k
Sold 1,093 shares
@ $59.532, valued at
$65.1k
Sold 1,402 shares
@ $59.5378, valued at
$83.5k
Exercised 173 options to buy
@ $33.63, valued at
$5.8k
Exercised 2,995 options to buy
@ $33.02, valued at
$98.9k
Exercised 3,948 options to buy
@ $33.63, valued at
$132.8k
Exercised 157 options to buy
@ $33.63, valued at
$5.3k
Exercised 1,093 options to buy
@ $33.02, valued at
$36.1k
|
|
| 05/23/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 6,403 shares
@ $58.9553, valued at
$377.5k
Sold 1,913 shares
@ $58.9783, valued at
$112.8k
Sold 100 shares
@ $59.66, valued at
$6k
|
|
| 05/19/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 800 shares
@ $58.5175, valued at
$46.8k
Sold 7,248 shares
@ $58.5, valued at
$424k
Sold 788 shares
@ $58.7143, valued at
$46.3k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 2,571 shares
@ $50.0476, valued at
$128.7k
Exercised 2,571 options to buy
@ $18.01, valued at
$46.3k
|
|
| 03/31/2023 |
4
| Utter Christine Marie (SVP, FINANCE & CAO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 3,247 shares
@ $47.798, valued at
$155.2k
Sold 1,441 shares
@ $47.7752, valued at
$68.8k
Exercised 4,688 options to buy
@ $40.45, valued at
$189.6k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Utter Christine Marie (SVP, FINANCE & CAO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 325 shares
@ $45.628, valued at
$14.8k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 375 shares
@ $45.628, valued at
$17.1k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Peltz Stuart Walter (CEO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 284 shares
@ $47.4513, valued at
$13.5k
|
|
| 01/26/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 359 shares
@ $47.4513, valued at
$17k
|
|
| 01/26/2023 |
4
| Hill Emily Luisa (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 223 shares
@ $47.4513, valued at
$10.6k
|
|
| 01/26/2023 |
4
| Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 44 shares
@ $47.4513, valued at
$2.1k
|
|
| 01/12/2023 |
4
| Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 473 shares
@ $42.9329, valued at
$20.3k
Sold 27 shares
@ $42.9329, valued at
$1.2k
Sold 383 shares
@ $44.3596, valued at
$17k
Sold 27 shares
@ $44.3596, valued at
$1.2k
|
|
| 01/12/2023 |
4
| Boulding Mark Elliott (EXEC. VP AND CLO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 590 shares
@ $42.9329, valued at
$25.3k
Sold 495 shares
@ $44.3596, valued at
$22k
|
|
| 01/12/2023 |
4
| Hill Emily Luisa (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 497 shares
@ $42.9329, valued at
$21.3k
Sold 418 shares
@ $44.3596, valued at
$18.5k
|
|
| 01/12/2023 |
4
| Klein Matthew B. (COO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 2,273 shares
@ $42.9329, valued at
$97.6k
Sold 2,244 shares
@ $44.3596, valued at
$99.5k
|
|
| 01/12/2023 |
4
| Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 663 shares
@ $42.9329, valued at
$28.5k
Sold 571 shares
@ $44.3596, valued at
$25.3k
|
|
| 01/12/2023 |
4
| Peltz Stuart Walter (CEO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 1,228 shares
@ $42.9329, valued at
$52.7k
Sold 571 shares
@ $42.9329, valued at
$24.5k
Sold 1,189 shares
@ $44.3596, valued at
$52.7k
Sold 492 shares
@ $44.3596, valued at
$21.8k
|
|
| 01/12/2023 |
4
| Utter Christine Marie (SVP, FINANCE & CAO) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 489 shares
@ $42.9329, valued at
$21k
Sold 417 shares
@ $44.3596, valued at
$18.5k
|
|
|
|
|